Brass Tax Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$274K Sell
10,768
-38
-0.4% -$938 0.05% 197
2025
Q2
$262K Sell
10,806
-1,777
-14% -$41.4K 0.05% 186
2025
Q1
$319K Sell
12,583
-114
-0.9% -$2.98K 0.07% 149
2024
Q4
$337K Sell
12,697
-946
-7% -$25.7K 0.07% 131
2024
Q3
$395K Buy
13,643
+3,303
+32% +$96.4K 0.08% 109
2024
Q2
$289K Buy
10,340
+2,028
+24% +$55.8K 0.13% 97
2024
Q1
$231K Buy
+8,312
New +$231K 0.12% 100

Other funds holding PFE

Brass Tax Wealth Management's PFE Position: Q3 2025 in Review

Brass Tax Wealth Management reduced its Pfizer (PFE) stake by 0.35% in Q3 2025, selling an estimated $938 and leaving 10,768 shares worth $274K. The position accounts for 0.05% of the portfolio, ranked #197.

Brass Tax Wealth Management first reported a position in PFE in Q1 2024 and has held it in 7 quarters since. The position peaked at $395K in Q3 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Brass Tax Wealth Management held 10,768 shares of Pfizer worth $274K as of Q3 2025.
  • Brass Tax Wealth Management sold 38 Pfizer shares in Q3 2025, an estimated $938.
  • Pfizer made up 0.05% of Brass Tax Wealth Management's portfolio in Q3 2025, its #197 holding.
  • Brass Tax Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 7 quarters since.
  • Brass Tax Wealth Management's Pfizer position peaked at $395K in Q3 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Brass Tax Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.